Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application
Serena Silvestro, Placido Bramanti, Emanuela Mazzon
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3979-3979
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Advances in the development of new biomarkers for Alzheimer’s disease
Timofey O. Klyucherev, Pawel K. Olszewski, Alena A. Shalimova, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 158
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Donovan McGrowder, Fabian Miller, Kurt Vaz, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 215-215
Open Access | Times Cited: 105
MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy
Yao-Bo Li, Qiang Fu, Mei Guo, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
MiRNAs as major players in brain health and disease: current knowledge and future perspectives
Sarika V. Kapplingattu, Sujata Bhattacharya, Yogita K. Adlakha
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
miR-124 and Parkinson’s disease: A biomarker with therapeutic potential
Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
Pharmacological Research (2019) Vol. 150, pp. 104515-104515
Closed Access | Times Cited: 112
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Prashanth Gowda, P. Hemachandra Reddy, Subodh Kumar
Ageing Research Reviews (2021) Vol. 73, pp. 101529-101529
Open Access | Times Cited: 102
The Regulation of microRNAs in Alzheimer's Disease
Xianjuan Kou, Dandan Chen, Ning Chen
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 95
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease
María Serpente, Chiara Fenoglio, Marianna D’Anca, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1443-1443
Open Access | Times Cited: 88
Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases
Yu Su, Bixi Sun, Xiaoshu Gao, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 87
microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
Yuhai Zhao, Vivian Jaber, Peter N. Alexandrov, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 79
Diet quality, gut microbiota, and microRNAs associated with mild cognitive impairment in middle-aged and elderly Chinese population
Xiaona Zhang, Yushan Wang, Wen Liu, et al.
American Journal of Clinical Nutrition (2021) Vol. 114, Iss. 2, pp. 429-440
Open Access | Times Cited: 75
Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives
Saqer Al Abdullah, Lubna Najm, Liane Ladouceur, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 37
Open Access | Times Cited: 25
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease
Nourhan M. Abdelmaksoud, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155007-155007
Closed Access | Times Cited: 23
Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
Kaden Nystuen, Shannon M. McNamee, Monica Akula, et al.
Bioengineering (2024) Vol. 11, Iss. 1, pp. 45-45
Open Access | Times Cited: 12
Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis
Monika Sharma, Ankur Kumar Tanwar, Paresh Kumar Purohit, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 161, pp. 105685-105685
Closed Access | Times Cited: 11
The role of synaptic microRNAs in Alzheimer's disease
Subodh Kumar, P. Hemachandra Reddy
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 12, pp. 165937-165937
Open Access | Times Cited: 62
A network-based analysis of key pharmacological pathways of Andrographis paniculata acting on Alzheimer's disease and experimental validation
Lili Gu, Jiaqi Lü, Qin Li, et al.
Journal of Ethnopharmacology (2019) Vol. 251, pp. 112488-112488
Closed Access | Times Cited: 60
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
Ida Manna, Selene De Benedittis, Andrea Quattrone, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 243-243
Open Access | Times Cited: 54
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities
Nermeen Z. Abuelezz, Fayza Eid Nasr, Mohammad A. Abdulkader, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 42
Differential microRNA expression analyses across two brain regions in Alzheimer’s disease
Valerija Dobričić, Marcel Schilling, Jessica Schulz, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 36
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
Ivana Raffaele, Serena Silvestro, Emanuela Mazzon
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4736-4736
Open Access | Times Cited: 20
Non-invasive Biomarkers for Early Detection of Alzheimer’s Disease: a New-Age Perspective
Niyamat M. A. Chimthanawala, Akash Haria, Sadhana Sathaye
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 212-223
Closed Access | Times Cited: 17
Integrated Analysis of mRNA-seq and miRNA-seq to Identify c-MYC, YAP1 and miR-3960 as Major Players in the Anticancer Effects of Caffeic Acid Phenethyl Ester in Human Small Cell Lung Cancer Cell Line
Fei Mo, Ya Luo, Dian Fan, et al.
Current Gene Therapy (2020) Vol. 20, Iss. 1, pp. 15-24
Closed Access | Times Cited: 41
MicroRNA‑4722‑5p and microRNA‑615‑3p serve as potential biomarkers for Alzheimer's disease
Yan Liu, Yuhao Xu, Ming Yu
Experimental and Therapeutic Medicine (2022) Vol. 23, Iss. 3
Open Access | Times Cited: 23
Printed Electrochemical Strip for the Detection of miRNA-29a: A Possible Biomarker Related to Alzheimer’s Disease
Antonella Miglione, Ada Raucci, Jussara Amato, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 45, pp. 15558-15563
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top